Five-year outcomes of patients supported with HeartMate 3: a single-centre experience.
Jan D SchmittoSilvia MarianiTong LiGuenes DoganJasmin S HankeChristoph BaraYuriy PyaDaniel ZimpferThomas KrabatschJens GarbadeVivek RaoMichiel MorshuisFriedhelm BeyersdorfSilvana MarascoIvan NetukaJohann BauersachsAxel HaverichPublished in: European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery (2021)
This study reports the longest single-centre follow-up of the HeartMate 3, showing excellent haemocompatibility over time with high survival and low complication rates at 5 years.
Keyphrases
- end stage renal disease
- chronic kidney disease
- newly diagnosed
- ejection fraction
- left ventricular assist device
- peritoneal dialysis
- prognostic factors
- emergency department
- patient reported outcomes
- metabolic syndrome
- adipose tissue
- insulin resistance
- weight loss
- skeletal muscle
- glycemic control
- drug induced
- adverse drug